A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes

PHASE2CompletedINTERVENTIONAL
Enrollment

256

Participants

Timeline

Start Date

June 18, 2018

Primary Completion Date

June 25, 2019

Study Completion Date

July 15, 2019

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Cyclo-Z

Cyclo (His-Pro) and zinc

OTHER

Placebo

Matching placebo

Trial Locations (20)

30071

Study Site 21, Peachtree Corners

30078

Study Site 17, Snellville

32720

Study Site 19, DeLand

32806

Study Site 15, Orlando

33134

Study Site 13, Coral Gables

33140

Study Site 12, Miami Beach

33155

Study Site 14, Miami

33711

Study Site 16, St. Petersburg

35216

Study Site 26, Birmingham

36207

Study Site 29, Anniston

44142

Study Site 18, Cleveland

48723

Study Site 30, Caro

78220

Study Site 22, San Antonio

78249

Study Site 11, San Antonio

89106

Study Site 24, Las Vegas

91606

Study Site 23, North Hollywood

91763

Study Site 10, Montclair

91911

Study Site 27, Chula Vista

91942

Study Site 28, La Mesa

02747

Study Site 20, North Dartmouth

Sponsors
All Listed Sponsors
collaborator

InClin, Inc.

UNKNOWN

collaborator

FGK Clinical Research GmbH

INDUSTRY

lead

NovMetaPharma Co., Ltd.

INDUSTRY